AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05623332 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Maraciclatide
Description: Imaging marker that binds to AVB3/5 lesions
Study NCT04424537 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control diet
Description: Meal replacement beverages made with whey protein
Study NCT04424537 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low branched-chain amino acids(BCAA) diet
Description: meal replacement beverages (MRBs) made with BCAD2 powder (lacking BCAAs).
Study NCT04424537 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Low protein diet
Description: meal replacement beverages(MRBs) containing low protein
Study NCT05856877 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Human nasal insulin
Description: single dose of 160 U of human insulin as nasal spray
Study NCT05856877 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single dose of placebo solution as nasal spray
Study NCT05858086 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Novel same-day discharge protocol after total joint arthroplasty
Description: Preoperative gait/stair training with physical therapy, then postoperative ambulation with nursing after total joint arthroplasty
Study NCT05858086 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional postoperative physical therapy clearance
Description: Physical therapy evaluation and clearance after total joint arthroplasty
Study NCT04642625 — intervention group
Intervention type: OTHER
Intervention: Visual Analog Score
Description: The VAS is a widely used tool in research and clinical practice, and its reliability and validity in pain assessment has been clearly demonstrated. It consists of a 100 mm line. 0 cm no pain, 10 cm is associated with 'worst possible pain'. The patient is asked to mark the line to 'score' the pain. VAS values of 1cm - 3cm weak, 4cm - 6cm moderate, and >7cm are the indicators of severe pain.
Study NCT04642625 — intervention group
Intervention type: OTHER
Intervention: patient satisfaction
Description: The patient's satisfaction with postoperative pain treatment will be recorded. 4 options; excellent, good, medium and bad.
Study NCT06404814 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Description: (TENS) is a method of pain relief involving the use of a mild electrical current
Study NCT06404814 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Muscle Energy Technique
Description: n Spencer's technique, there are seven steps as follows: shoulder extension along with elbow flexion, shoulder flexion with elbow extension, circumduction with compression, circumduction with distraction, shoulder abduction and internal rotation with elbow flexion, shoulder adduction and external rotation with elbow
Study NCT06460545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: sIPV (booster dose at 18 months of age)
Description: Sabin-strain-based inactivated vaccine (Vero cells), 0.5mL for each dose at 18 months of age for the booster one
Study NCT06460545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HepA-L
Description: Freeze-dried/lyophilized live-attenuated hepatitis A virus vaccine, 1.0mL for each dose at 18 months of age
Study NCT06460545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HepA-I
Description: Inactivated hepatitis A virus vaccine, 0.5mL for each dose, two doses at 18 and 24 months of age, respectively
Study NCT06144554 — intervention group
Intervention type: DEVICE
Intervention: Omnipod 5
Description: The Omnipod 5 System consists of a tubeless insulin Pod and the Omnipod® 5 App, installed on a designated Controller or compatible Android smartphone. The Omnipod 5 System works with the Dexcom G6® Continuous Glucose Monitoring System to continuously adapt and automatically deliver insulin according to personal needs.~Every two weeks while on the Omnipod 5 system, participants will receive a push notification to complete assessments including any severe hypoglycemia or diabetic ketoacidosis events experienced since the prior assessment.
Study NCT04448002 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AIM2ACT
Description: AIM2ACT is a mobile health tool that is designed to facilitate collaborative asthma management between early adolescents and their caregivers. AIM2ACT contains the following components: 1) ecological momentary assessment to identify personalized strengths and weaknesses in asthma self-management behaviors; 2) collaborative identification and tracking of goals that help early adolescents to become increasingly independent in managing their asthma; and 3) a suite of engaging skills training videos to help dyads understand how to use AIM2ACT and work together to set asthma self-management goals, develop and achieve the goals articulated in a behavioral contract, and engage in problem-solving communication.
Study NCT04448002 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: mHealth Attention Control Condition
Description: Dyads in the mHealth attention control condition will not receive personalized asthma management feedback, will not be guided through collaborative identification and tracking of asthma self-management goals, and will not have access to skills training videos. Instead, dyads will receive static educational information on their smartphones about behavioral management techniques they can use to target improving asthma self-management.
Study NCT05575453 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kvatchii Portal
Description: Online education portal
Study NCT05020028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Description: Patients will be dispensed enough 25mg cannabidiol (CBD) Orally Disintegrating Tablets (ODT) to take a standard dose of 50mg three times daily for 84 days.
Study NCT05020028 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 25mg Placebo ODT looks like the cannabidiol (CBD) Orally Disintegrating Tablets (ODT), but contains no active ingredients.
Study NCT04698343 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Noninvasive Peripheral Nerve Stimulation (NPNS)
Description: NPNS device programmed to deliver active stimulation.
Study NCT06369870 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine Hydrochloride 0.25 % Injectable Solution
Description: After wound closure, the IPP-PSP block is performed at the level of the 4th rib. At the pre-axillary line, the pectoralis major, the pectoralis minor and the serratus anterior muscle are identified. At first, the needle is positioned in the fascial plane between the pectoralis minor and the serratus anterior muscle. The needle position is confirmed by hydro-dissection of this plane with 2 mL of normal saline 0.9%.The 20 ml syringe with trial drug solution is injected in this pectoserratus plane (PSP). The needle tip is repositioned in the interpectoral plane between both the pectoralis major and minor muscle. The 10 ml syringe with trial drug solution is administered in this interpectoral plane (IPP).
Study NCT06369870 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Sodium chloride 0.9%
Description: Unilateral (right) IPP-PSP block with 30 mL normal saline 0.9%, administered after the closure of the wounds. The IPP-PSP block procedure will be carried out as described in the intervention description of the IPP-PSP block.
Study NCT05126563 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: HB-adMSCs (allogeneic)
Description: HB-adMSCs allogenic
Study NCT05126563 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo comarator
Study NCT05219825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathwork workshop
Description: Participants will complete 1.5 hours of breathwork session in addition to a total of 6 hours of brief psychotherapeutic intervention in a span of 1 week. The therapy sessions will occur both before and after the breathing session.
Study NCT05371769 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: chronic pain management education program
Description: The chronic pain management training program will be applied for 2 weeks. The training consists of 15 videos about theory and practice topics in chronic pain management. There are evaluation questions at the end of each video.
Study NCT05371769 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: No intervention
Description: No intervention will be made.
Study NCT06101043 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pectoral nerve block
Description: An ultrasound probe was placed obliquely over the second and third ribs below the lateral one-third of the clavicle. After identification of the anatomical structures, the needle was advanced along a superior-medial-to-inferior-lateral passage to the tissue plane between the pectoralis minor and serratus anterior muscles, and 20 mL ropivacaine (0.375% w/v) was injected at the level of the third rib. The anesthetic spread around the axilla, and the needle was withdrawn to the point in the plane between the pectoralis major and minor muscles. A second injection of 20 mL ropivacaine (0.375% w/v) was then delivered (PECS II).
Study NCT04725240 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Setmelanotide
Description: Setmelanotide for SC injection
Study NCT06560385 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: BLHK03
Description: BLHK03 consists of a blend of probiotics (20 billion CFU in 1 sachet) and prebiotic compounds
Study NCT06560385 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Active placebo
Description: Active placebo contains 5mcg of Vitamin B7
Study NCT06067516 — intervention group
Intervention type: OTHER
Intervention: Fluid resuscitations
Description: In line with the recommendations in the Surviving Sepsis Guide, fingertip capillary refill time (CRT) will be measured by applying pressure to the index finger for 15 seconds in the T1 time period after 30 mL/kg/3 hours crystalloid infusion.
Study NCT04657679 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ribociclib
Description: Patients will receive ribociclib 600 mg oral (PO) daily for 21 consecutive days of 28-day cycles and endocrine therapy with either letrozole or fulvestrant. Fulvestrant 500 mg intramuscular (IM) will be administered on days 1, 15, 29 of cycle one, and then monthly. Letrozole 2.5 mg oral daily continuously. If premenopausal women have not undergone bilateral salpingo- oophorectomy, they will receive a luteinizing hormone-releasing hormone (LHRH) agonist (e.g., goserelin leuprolide) for ovarian suppression in combination with fulvestrant or letrozole and ribociclib.
Study NCT06151405 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DGA Diet
Description: A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans (DGA)~Including:~* A variety of vegetables and fruits~* Grains, at least half of which are whole grains~* Fat-free or low-fat dairy~* A variety of protein foods, including seafood, lean meats and poultry, eggs, legumes, nuts, and seeds~* This healthy eating pattern also limits saturated fats and trans fats, added sugars, and sodium.
Study NCT06151405 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MCT Diet
Description: A fully provisioned isocaloric, isonitrogenous study diet following the Dietary Guidelines for Americans supplemented with medium chain triglycerides (MCT).
Study NCT06151405 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KETO Diet
Description: A fully provisioned isocaloric, isonitrogenous ketogenic study diet.
Study NCT05543603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacer Clorhexidina Colutorio
Description: 15 ml 0,12% Chlorhexidine, one minute rinse
Study NCT05543603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacer Clorhexidine 0.20% Colutorio
Description: 15 ml 0,2% Chlorhexidine, one minute rinse
Study NCT05543603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gingilacer Encías Delicadas Colutorio
Description: 15 ml 0,10% cymenol + 0,10% zinc chloride, one minute rinse
Study NCT05543603 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Distilled water
Description: 15 ml distilled water, one minute rinse
Study NCT04453657 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FamilyChildCare (provisional name of app)
Description: Parents will provide their child(ren) access to a smartphone, tablet, or computer for approximately 30 minutes, three times per week for 15 weeks with a total dosage of instruction of about 22.5 hours. Parents and providers will receive self-care, parenting, and parent engagement tips and resources through push notifications twice a day. Additionally, daily reminders will be sent to parents through push notification to give their child(ren) access to the learning games. After 15 weeks of app engagement, the providers and parents will be contacted by the PI to notify them of the 15 week time mark and provide the information for post-surveys via Qualtrics.
Study NCT05699187 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Face allotransplantation
Description: Facial allotransplantation
Study NCT05426928 — intervention group
Intervention type: OTHER
Intervention: Additional temperature monitoring/recording
Description: All patients in this study will receive the same standard of care treatment for their HIPEC procedure. The only difference will be the use of additional temperature probes to collect more robust data regarding intraabdominal temperature, and the prospective collection of actual boundary conditions of the system.
Study NCT04307771 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: m-Health application
Description: Dental Buddy is a mobile application that has been designed to improve oral hygiene maintenance behaviours in teenagers
Study NCT04307771 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: m-Health application
Description: Dental Buddy is a mobile application that has been designed to improve oral hygiene maintenance behaviours in teenagers
Study NCT05420506 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NROT1
Description: Dental anchored intestinal placement of obesity treatment device with endoscopic intervention
Study NCT05927285 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Vexus
Description: The VExUS group was considered the intervention group, where in addition to all the above, the decision for decongestant treatment was guided by the VExUS score until reaching a score that VExUS considered noncongestive, which was grade 0.
Study NCT05927285 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: The control group is considered the conventional approach, where the treatment was guided by improvement in clinical data, imaging, or laboratory studies during the daily evaluation until categorized as decongested
Study NCT05493891 — intervention group
Intervention type: OTHER
Intervention: Visual analogue scale (VAS)
Description: VAS is a reliable and valid method for assessing the intensity of low back pain (LBP)
Study NCT05493891 — intervention group
Intervention type: DEVICE
Intervention: Pressure Biofeedback Unit (PBU)
Description: PBU is a valid and reliable instrument for measuring the maximal voluntary isometric contraction of both lumbar multifidus and transversus abdominis muscles (core muscle strength)
Study NCT05027321 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preparation in Self-Hypnosis by anchoring
Description: Preparation in Self-Hypnosis by anchoring just before examination
Study NCT05027321 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conversational Hypnosis
Description: Conversational Hypnosis during examination
Study NCT05027321 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preparation in Self-Hypnosis by anchoring + Conversational Hypnosis
Description: Preparation in Self-Hypnosis by anchoring just before examination combied with Conversational Hypnosis during examination
Study NCT06100562 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Dance Program
Description: * Participants will attend a 2x/weekly adaptive dance session for 10 weeks. If participants miss a class due to illness or an unexpected event (loss of transportation, family emergency/need) they will receive a video of the content missed and can complete the session at home.~* Each class will start with a 10 min warm-up that will include stretching and motor games.~* Learn a section of choreography every session using action-based intervention for 30 minutes.~* Break for 5 min.~* Improvisation part of class for 10 min.~* Cool-down for 5 min.
Study NCT05343754 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyperbaric oxygen
Description: Hyperbaric treatment will consist of 30 daily treatments in the first 6 weeks of the study, except during the weekends. After compression for 10 minutes patients will receive 80minutes (4 times 20 minutes) 100% O2 with 3 airbrakes (21% O2) of 5 minutes at 2.4-2.5 ATA, and then 10 minutes decompression with the first part of decompression till 0.3 ATA with 100% oxygen (this will usually take seven minutes). The last 0.3 ATA will be decompressed with air. In total one hyperbaric session will be 110 minutes. Treatment will start directly at the beginning of the study.
Study NCT05343754 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: In order to compare efficacy, patients that do not wish to undergo hyperbaric treatment, will serve as a control group. At baseline they will be asked for the reason they do not wish to undergo hyperbaric treatment. All patients and controls will be asked to report pain scores using a numeric pain rating scale (NRS) and quality of life (Wound-Q) questionnaires. They will continue to receive standard care as deemed necessary by their primary physician.
Study NCT06219694 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser Acupuncture
Description: Laser stimulation energy of 4.5 J for 30 seconds at each of the following acupoints: bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3)
Study NCT06219694 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham treatment with no laser output, stimulate the same acupoints as laser acupuncture group as follows: 30 seconds at bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3)~After 6 months followed up, the sham group received truely Laser stimulation energy of 4.5 J for 30 seconds at each of the following acupoints: bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3), and followed up for another 3 months.
Study NCT05876689 — intervention group
Intervention type: DEVICE
Intervention: DREAM OCT
Description: Swept Source OCT (similar to Zeiss Plex Elite)
Study NCT06542029 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Groups 4 Health (G4H)
Description: Groups 4 Health, G4H, (Ryhmät kuntoon) at the University of Helsinki is a manualized group intervention for the students that focuses on social connectedness and aims at improving general health and life satisfaction. G4H groups are facilitated by two psychology MA students (or licensed psychologists) carefully trained for the intervention and mentored by experienced clinical psychologists. G4H consists of five 90 minutes sessions that aim to give participants the knowledge and skills they need to effectively manage their social group memberships and identities. Each session contains exercises and discussions described in the G4H workbook that target different aspects of group life identified within the social identity model of identity change and put the Social Identity Approach to Health -model to practice. Students earn 2 ECTS (European Credit Transfer and Accumulation System) credits for completing the intervention.
Study NCT06542029 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The study psychologists' group intervention
Description: University of Helsinki study psychology team organizes group interventions for various challenges of studying for bachelor's and master's students. These groups offer client-centered peer support facilitated by one to two study psychologists. Recurring themes in the groups include: challenges in attentiveness, independent studying, and scientific writing, as well as support for re-entering the studies after a break. The approach in the different thematic groups is largely similar: short presentations, group discussions and practices. These groups have been implemented as both face-to-face and remote meetings. One group typically lasts for a study period and comprises five to six 90 minutes sessions. Typical group size is six to 12 students.
Study NCT06542029 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Towards better well-being and studying -online course
Description: Towards better well-being and studying -online course (Kohti parempaa opiskelua) is an optional, seven-week online course that aims to foster university students' well-being and study skills. It is available for all University of Helsinki students. The course is based on principles of Acceptance and Commitment therapy and aims to support the development of psychological flexibility. The course takes place in Moodle platform and the students earn 3 ECTS credits for completing it. This course progresses week by week and has six central themes which include individual work in practicing psychological flexibility skills as well as study skills on a weekly basis and weekly group discussion.
Study NCT05687604 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: multiple behavior change therapy
Description: goals related to their physical activity, smoking, and/or obesity, and will be asked to meet those goals weekly/daily. Participants will also be asked to record their weight, activity, and/or cigarette smoking daily, and will complete 16 telehealth sessions with study staff across the 12 months of the study. Will have physical measures taken or extracted from the medical record at baseline, 3 months, 6 months, and 12 months.